A Study of Abemaciclib (LY2835219) in Combination With Other Anti-Cancer Treatments in Children and Young Adult Participants With Solid Tumors, Including Neuroblastoma
Eli Lilly and Company
Eli Lilly and Company
Pediatric Brain Tumor Consortium
Washington University School of Medicine
Stanford University
Milton S. Hershey Medical Center
Columbia University
Mayo Clinic
Istari Oncology, Inc.
Hackensack Meridian Health
Mayo Clinic
Washington University School of Medicine
BioMimetix JV, LLC
St. Joseph's Hospital and Medical Center, Phoenix
Washington University School of Medicine
Thomas Jefferson University
University of Pittsburgh
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
University of California, San Francisco
Children's Oncology Group
University of Florida
Dartmouth-Hitchcock Medical Center
National Cancer Institute (NCI)
Massachusetts General Hospital
National Cancer Institute (NCI)
Dana-Farber Cancer Institute
Virginia Commonwealth University
Radiation Therapy Oncology Group
Basilea Pharmaceutica
Pediatric Brain Tumor Consortium
Celgene
Istari Oncology, Inc.
Memorial Sloan Kettering Cancer Center
Candel Therapeutics, Inc.
Lumos Pharma
Exelixis
Novartis
Southern Illinois University
Sumitomo Pharma America, Inc.
Sumitomo Pharma America, Inc.
H. Lee Moffitt Cancer Center and Research Institute
Eisai Inc.
Novartis
Duke University
TVAX Biomedical
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
M.D. Anderson Cancer Center
Wake Forest University Health Sciences
TVAX Biomedical